United States Pharmaceuticals

Elanco Animal Health Inc (ELAN)

Track

Elanco Animal Health experienced two insider trading transactions over the past ninety days, both involving executive purchases totaling approximately $199,781. These acquisitions occurred following a positive earnings report where the company exceeded expectations. The stock price has remained relatively stable, showing a modest 1.8% increase during this period.
Ticker: ELAN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Elanco Animal Health Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 7 Aug 2026
Value US$1,291,112.97 | Price 349.41 | Shares 84,293 (-5.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-08-07 B Purchase
2.5
VanHimbergen Robert M

EVP and CFO

Officer
84,293 -5.8%
349.41
US$1,291,113 		84,293 -5.8% 349.41 US$1,291,113
2026-08-10 2026-08-07 B Purchase
0.7
Herendeen Paul
Non-Executive Director
78,826 -43.7%
249.70
US$1,023,614 		78,826 -43.7% 249.70 US$1,023,614
2026-05-19 2026-05-15 B Purchase
1.3
Modi Rajeev A.

SEE REMARKS

Officer
70,690 -10.7%
469.83
US$2,925,859 		70,690 -10.7% 469.83 US$2,925,859
2026-05-19 2026-05-15 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
4,971 +3.0%
20.09
US$99,843 		4,971 +3.0% 20.09 US$99,843
2025-12-16 2025-12-12 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
10,000 +8.2%
21.30
US$213,000 		10,000 +8.2% 21.30 US$213,000
2025-12-15 2025-12-11 B Purchase
2.5
VanHimbergen Robert M

EVP and CFO

Officer
6,950 +5.9%
21.64
US$150,426 		6,950 +5.9% 21.64 US$150,426
2025-12-15 2025-12-11 PP Planned purchase
1.3
Modi Rajeev A.

SEE REMARKS

Officer
4,500 +3.8%
21.33
US$95,985 		4,500 +3.8% 21.33 US$95,985
2025-12-15 2025-12-11 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
22,000 +15.2%
21.75
US$478,496 		22,000 +15.2% 21.75 US$478,496
2025-08-11 2025-08-11 PrS Proposed sale
3.6
Todd S and Jennifer G Young Living Trust Dtd 08/03/2021

Former CFO
49,333
16.82
US$830,000 		49,333 16.82 US$830,000
2025-03-11 2025-03-11 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
10,000 +9.9%
10.20
US$102,000 		10,000 +9.9% 10.20 US$102,000
2025-03-11 2025-03-07 B Purchase
3.7
Kurzius Lawrence Erik
Non-Executive Director
10,000 +10.9%
10.90
US$109,000 		10,000 +10.9% 10.90 US$109,000
2025-03-07 2025-03-05 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
25,000 +13.5%
10.90
US$272,558 		25,000 +13.5% 10.90 US$272,558
2024-08-26 2024-08-22 B Purchase
2.4
Harrington Michael J
Non-Executive Director
3,500 +4.5%
14.85
US$51,974 		3,500 +4.5% 14.85 US$51,974
2024-08-13 2024-08-12 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
100,000 +222.2%
13.01
US$1,300,610 		100,000 +222.2% 13.01 US$1,300,610
2024-05-23 2024-05-21 B Purchase
2.2
DOYLE WILLIAM F
Non-Executive Director
15,000 +24.5%
16.98
US$254,700 		15,000 +24.5% 16.98 US$254,700
2024-03-12 2024-03-08 B Purchase
2.2
DOYLE WILLIAM F
Non-Executive Director
15,000 +32.4%
16.30
US$244,500 		15,000 +32.4% 16.30 US$244,500
2024-03-12 2024-03-08 B Purchase
2.4
Harrington Michael J
Non-Executive Director
3,100 +4.2%
16.29
US$50,494 		3,100 +4.2% 16.29 US$50,494
2024-03-08 2024-03-06 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +12.1%
16.14
US$322,808 		20,000 +12.1% 16.14 US$322,808
2023-03-15 2023-03-14 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +3.1%
9.55
US$47,750 		5,000 +3.1% 9.55 US$47,750
2023-03-15 2023-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +3.2%
9.46
US$47,288 		5,000 +3.2% 9.46 US$47,288
2023-03-13 2023-03-10 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
15,000 +50.0%
9.60
US$143,972 		15,000 +50.0% 9.60 US$143,972
2023-03-07 2023-03-03 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +6.9%
11.13
US$111,300 		10,000 +6.9% 11.13 US$111,300
2022-11-15 2022-11-11 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
7,500 +21.9%
13.24
US$99,267 		7,500 +21.9% 13.24 US$99,267
2022-09-09 2022-09-09 B Purchase
1.3
Modi Rajeev A.

SEE REMARKS

Officer
6,700 +19.4%
14.90
US$99,830 		6,700 +19.4% 14.90 US$99,830
2022-09-09 2022-09-09 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +16.0%
15.18
US$303,614 		20,000 +16.0% 15.18 US$303,614
2022-09-09 2022-09-09 B Purchase
0.7
Herendeen Paul
Non-Executive Director
10,000 +136.9%
15.03
US$150,250 		10,000 +136.9% 15.03 US$150,250
2022-09-09 2022-09-09 B Purchase
3.4
Simmons Jeffrey N

PRESIDENT, CEO AND DIRECTOR

Executive Director
30,000 +inf%
14.54
US$436,146 		30,000 +inf% 14.54 US$436,146
2022-05-24 2022-05-20 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +8.7%
23.33
US$233,269 		10,000 +8.7% 23.33 US$233,269
2022-05-13 2022-05-11 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
10,000 +41.3%
22.03
US$220,284 		10,000 +41.3% 22.03 US$220,284
2022-03-02 2022-03-02 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +4.5%
29.00
US$145,000 		5,000 +4.5% 29.00 US$145,000
2022-03-03 2022-03-01 B Purchase
1.8
Anand Kapila K
Non-Executive Director
1,000 +3.8%
28.48
US$28,479 		1,000 +3.8% 28.48 US$28,479
2022-03-02 2022-03-01 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +4.8%
28.66
US$143,322 		5,000 +4.8% 28.66 US$143,322
2021-12-02 2021-11-30 B Purchase
2.4
Harrington Michael J
Non-Executive Director
2,500 +9.7%
29.25
US$73,122 		2,500 +9.7% 29.25 US$73,122
2021-12-02 2021-11-30 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
10,000 +10.5%
29.38
US$293,794 		10,000 +10.5% 29.38 US$293,794
2021-11-17 2021-11-15 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
5,000 +5.6%
31.79
US$158,934 		5,000 +5.6% 31.79 US$158,934
2021-05-12 2021-05-11 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
25,000 +55.6%
32.44
US$811,000 		25,000 +55.6% 32.44 US$811,000
2020-12-03 2020-12-03 S Sale
1.6
BAYER AKTIENGESELLSCHAFT
Large shareholder
54,500,000 -74.7%
29.84
US$1,626,367,200 		54,500,000 -74.7% 29.84 US$1,626,367,200
2020-08-28 2020-08-28 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
5,000 +12.5%
28.62
US$143,100 		5,000 +12.5% 28.62 US$143,100
2020-08-28 2020-08-27 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
5,000 +16.1%
28.24
US$141,200 		5,000 +16.1% 28.24 US$141,200
2020-08-24 2020-08-21 B Purchase
2.9
HOOVER R DAVID

See Remarks

Non-Executive Director
10,000 +47.4%
26.94
US$269,400 		10,000 +47.4% 26.94 US$269,400
2020-08-19 2020-08-19 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
9,580 +65.4%
26.20
US$250,996 		9,580 +65.4% 26.20 US$250,996
2020-08-07 2020-08-06 B Purchase
3.4
GARCIA ART A
Non-Executive Director
2,000 +28.3%
24.76
US$49,520 		2,000 +28.3% 24.76 US$49,520
2020-08-04 2020-08-03 B Purchase
3.6
YOUNG TODD S.

See Remarks

Officer
5,000 +inf%
23.94
US$119,700 		5,000 +inf% 23.94 US$119,700
2020-08-04 2020-08-03 B Purchase
3.6
YOUNG TODD S.

See Remarks

Officer
2,000 +inf%
23.85
US$47,700 		2,000 +inf% 23.85 US$47,700
2020-03-16 2020-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
12,000 +42.9%
21.97
US$263,640 		12,000 +42.9% 21.97 US$263,640
2020-03-11 2020-03-09 B Purchase
2.4
Harrington Michael J
Non-Executive Director
4,000 +31.3%
23.84
US$95,360 		4,000 +31.3% 23.84 US$95,360
2020-03-06 2020-03-06 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
3,000 +25.8%
25.15
US$75,450 		3,000 +25.8% 25.15 US$75,450
2020-03-06 2020-03-04 B Purchase
1.8
Anand Kapila K
Non-Executive Director
1,000 +8.1%
26.86
US$26,860 		1,000 +8.1% 26.86 US$26,860
2020-03-03 2020-03-02 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
3,900 +16.2%
27.40
US$106,860 		3,900 +16.2% 27.40 US$106,860
2020-03-03 2020-02-28 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
4,100 +20.5%
26.99
US$110,659 		4,100 +20.5% 26.99 US$110,659
2019-11-25 2019-11-22 B Purchase BILBREY JOHN P Non-Executive Director
3,766 +47.8%
26.58
US$100,100 		3,766 +47.8% 26.58 US$100,100
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.29
US$1,998 		76 +inf% 26.29 US$1,998
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.27
US$1,996 		76 +inf% 26.27 US$1,996
2019-11-20 2019-11-18 B Purchase
2.3
Urbanek David Alan

See Remarks
76 +inf%
26.21
US$1,992 		76 +inf% 26.21 US$1,992
2019-09-12 2019-09-11 B Purchase
2.0
Kochevar Deborah Turner
1,000 +35.9%
27.95
US$27,950 		1,000 +35.9% 27.95 US$27,950
2019-09-05 2019-09-04 B Purchase
3.6
YOUNG TODD S.

See Remarks
10,000 +53.0%
26.57
US$265,700 		10,000 +53.0% 26.57 US$265,700
2019-09-05 2019-09-04 B Purchase
3.4
Simmons Jeffrey N

President, CEO & Director

Executive Director
75,750 +19.2%
26.55
US$2,011,162 		75,750 +19.2% 26.55 US$2,011,162
2019-08-26 2019-08-22 B Purchase Hicks Michael-Bryant

See Remarks

Officer
11,030 +48.2%
26.65
US$293,905 		11,030 +48.2% 26.65 US$293,905
2019-08-26 2019-08-22 B Purchase HOOVER R DAVID Non-Executive Director
15,000 +1630.4%
26.96
US$404,400 		15,000 +1630.4% 26.96 US$404,400
2019-05-15 2019-05-13 B Purchase
3.3
BILBREY JOHN P
Non-Executive Director
7,750 +inf%
32.39
US$251,022 		7,750 +inf% 32.39 US$251,022
2019-08-26 2019-04-22 B Purchase Harrington Michael J Non-Executive Director
3,500 +125.8%
26.75
US$93,608 		3,500 +125.8% 26.75 US$93,608
2019-03-14 2019-03-13 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
20,000 +inf%
31.43
US$628,586 		20,000 +inf% 31.43 US$628,586
2019-03-13 2019-03-11 B Purchase
Kinard David S

See Remarks

Officer
7,977
0.00
US$0 		7,977 0.00 US$0
2019-03-13 2019-03-11 B Purchase
Schacht Aaron L

See Remarks

Officer
1,227
0.00
US$0 		1,227 0.00 US$0
2019-03-13 2019-03-11 B Purchase
3.4
Simmons Jeffrey N

Presiident, CEO & Director

Executive Director
37,301
0.00
US$0 		37,301 0.00 US$0
2019-03-13 2019-03-11 B Purchase
2.3
Urbanek David Alan

See Remarks

Officer
2,021
0.00
US$0 		2,021 0.00 US$0
2019-03-13 2019-03-11 B Purchase
Cabral Ramiro Martin

See Remarks

Officer
1,227
0.00
US$0 		1,227 0.00 US$0
2019-03-13 2019-03-11 B Purchase
2.9
HOOVER R DAVID
Non-Executive Director
920
0.00
US$0 		920 0.00 US$0
2018-09-26 2018-09-24 B Purchase Meer James M

Chief Accounting Officer
225 +inf%
24.00
US$5,400 		225 +inf% 24.00 US$5,400
2018-09-26 2018-09-24 B Purchase Urbanek David Alan

See Remarks
500 +inf%
24.00
US$12,000 		500 +inf% 24.00 US$12,000
2018-09-26 2018-09-24 B Purchase Anand Kapila K
1,200 +inf%
24.00
US$28,800 		1,200 +inf% 24.00 US$28,800
2018-09-26 2018-09-24 B Purchase Kinard David S

See Remarks
2,500 +inf%
24.00
US$60,000 		2,500 +inf% 24.00 US$60,000
2018-09-26 2018-09-24 B Purchase Cabral Ramiro Martin

See Remarks
1,000 +inf%
24.00
US$24,000 		1,000 +inf% 24.00 US$24,000
2018-09-26 2018-09-24 B Purchase Hicks Michael-Bryant

See Remarks
5,000 +inf%
24.00
US$120,000 		5,000 +inf% 24.00 US$120,000
2018-09-26 2018-09-24 B Purchase Schacht Aaron L

See Remarks
400 +inf%
24.00
US$9,600 		400 +inf% 24.00 US$9,600
Explore more

More insider trading research around Elanco Animal Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America